44 unknown. 44 Phase 2, 12 Phase 3, 6 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 44 | Unknown 44 |
| Phase 3 | 12 | Unknown 12 |
| Phase 1 | 6 | Unknown 6 |
Follow Respiratory Hypersensitivity: new trials by email Literature Review of Respiratory Hypersensitivity trials Research Report on Respiratory Hypersensitivity
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Stapokibart Injection in Patients With Allergic Rhinitis Stapokibart Injection, Placebo - Allergic Rhinitis | Phase 2 | Unknown | Keymed Biosciences Co.Ltd | 120 | 2024-09-30 | 2024-11-08 |
| CIVETTA: Correlating Inflammatory Values of FEno, SympToms, SpuTum and Lung Function in Asthma Salbutamol, Fluticason either Beclometasone or Budesonide - Asthma | Phase 2 | Unknown | Università degli Studi di Ferrara | 80 | 2024-06-18 | 2024-07-03 |
| Study of CM310 in Subjects With Seasonal Allergic Rhinitis CM310 - Seasonal Allergic Rhinitis | Phase 2 | Unknown | Keymed Biosciences Co.Ltd | 100 | 2024-03-30 | 2023-12-14 |
| A Study of IL4Rα Monoclonal Antibody in Patients With Uncontrolled Seasonal Allergic Rhinitis. GR1802 injection-1, GR1802 injection-2, Placebo - Allergic Rhinitis | Phase 2 | Unknown | Zheng Liu ENT | 90 | 2023-09-07 | 2023-09-11 |
| Tezepelumab and Methacholine Airway Hyperresponsiveness in Participants With Mild Allergic Asthma Tezepelumab, Placebo - Asthma, Allergic | Phase 2 | Unknown | McMaster University | 34 | 2023-04-01 | 2023-02-23 |
| Assessing the Efficacy of CREWS01 to Decrease Usage of Rescue Inhalers in Moderate to Severe Asthmatic Adults Antipyrine-benzocaine otic solution, Glycerin with Oxyquinoline Sulfate - Asthma | Phase 2 | Unknown | Global United Pharmaceutical Corporation | 50 | 2023-04-01 | 2023-02-08 |
| Observation on the Efficacy and Mechanism of SLIT With Dust Mite Allergen for PAR Dust mite drops (trade name: Changdi, Zhejiang Tawu Biotechnology Co. Ltd.). - Allergic Rhinitis | Phase 2 / Phase 3 | Unknown | People's Hospital of Anshun City of Guizhou Province | 60 | 2022-12-01 | 2022-10-06 |
| A Phase II Study of 610 in Participants With Severe Eosinophilic Asthma 610 100mg, 610 300mg, placebo - Asthma | Phase 2 | Unknown | Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. | 120 | 2022-09-01 | 2022-09-06 |
| A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Phase II Trail Evaluating the Efficacy and Safety of GR1802 Injection in Patients with Moderate to Severe Asthma GR1802 injection, Placebo - Asthma | Phase 2 | Unknown | Genrix (Shanghai) Biopharmaceutical Co., Ltd. | 150 | 2022-07-19 | 2024-10-15 |
| A Study of MG-K10 in Subjects With Asthma MG-K10, Placebo - Asthma | Phase 1 / Phase 2 | Unknown | Shanghai Mabgeek Biotech.Co.Ltd | 180 | 2022-07-05 | 2023-08-21 |
| Using the Blood Eosinophil Count to Guide Systemic Corticosteroid Treatment in Asthma Exacerbations Standard care, Eosinophil-directed care - Asthma Attack, Asthma | Phase 2 | Unknown | Changi General Hospital | 110 | 2022-06-02 | 2024-08-21 |
| Treatment of Allergic Rhinitis and Chronic Polypous Rhinosinusitis With Olfactory Mucosa-derived Mesenchymal Stem Cells Olfactory mucosa-derived mesenchymal stem cells, Standard treatment of type Allergic Rhinitis according to the clinical protocols, Standard treatment of type Chronic Polypous Rhinosinusitis according to the clinical protocols - Allergic Rhinitis, Rhinosinusitis Chronic | Phase 1 / Phase 2 | Unknown | Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus | 60 | 2022-03-01 | 2022-01-19 |
| Benralizumab Initiated During Severe Asthma Attack Benralizumab 30 MG/ML [Fasenra], Placebos - Asthma Attack, Asthma | Phase 2 | Unknown | Singapore General Hospital | 128 | 2021-06-02 | 2021-07-23 |
| Acute Exacerbations Treated With BenRAlizumab (The ABRA Study) Benralizumab, Prednisolone - Asthma, COPD | Phase 2 | Unknown | University of Oxford | 158 | 2021-03-29 | 2024-01-23 |
| A Clinical Study on the Prevention of Mild to Moderate Intermittent Asthma With Chinese Medicine Weiyang Yuping Fang Weiyang Yuping Fang - Bronchial Asthma | Phase 2 | Unknown | Shanghai University of Traditional Chinese Medicine | 84 | 2020-10-01 | 2023-05-25 |
| Double Dose Magnesium Sulphate in Moderate-severe Asthma in Paediatrics Magnesium Sulfate, Placebo - Asthma in Children | Phase 2 / Phase 3 | Unknown | Oman Medical Speciality Board | 90 | 2020-08-01 | 2020-07-13 |
| Assessment of Suppression of Cutaneous Allergic Responses and Pruritis by Topical Minocycline Minocycline Topical, Placebos - Allergic Rhinitis, Asthma | Phase 2 | Unknown | State University of New York - Downstate Medical Center | 25 | 2019-09-26 | 2021-10-14 |
| Safety, Tolerability and Efficacy of S-1226 in Cystic Fibrosis and Non CF Bronchiectasis S-1226 - Cystic Fibrosis, Bronchiectasis | Phase 2 | Unknown | SolAeroMed Inc. | 12 | 2019-08-08 | 2021-06-16 |
| Clinical Study on Treatment of Chronic Persistent Bronchial Asthma Ke Chuan Liu Wei Granule, Yang He Ping Chuan Granule, Ke Chuan Liu Wei Granule placebo - Bronchial Asthma | Phase 2 | Unknown | Shanghai University of Traditional Chinese Medicine | 320 | 2018-02-01 | 2023-05-25 |
| Observation of Cough Variant Asthma Treated in Combination of Chanqin Granules. Chanqin granules - Cough Variant Asthma | Phase 1 / Phase 2 | Unknown | Shanghai University of Traditional Chinese Medicine | 120 | 2017-11-01 | 2017-10-24 |
Showing 20 of 44. Sign in to see all of them.
Asthma (31) · Rhinitis, Allergic (9) · Rhinitis, Allergic, Seasonal (5) · Hypersensitivity (3) · Conjunctivitis, Allergic (2) · Pulmonary Disease, Chronic Obstructive (2) · Rhinitis, Allergic, Perennial (2) · Status Asthmaticus (2) · Alveolitis, Extrinsic Allergic (1) · Bronchiectasis (1) · Cough-Variant Asthma (1) · Cystic Fibrosis (1) · Dermatitis, Atopic (1) · Food Hypersensitivity (1) · Inflammation (1)
Hypersensitivity, Immediate (44) · Immune System Diseases (44) · Respiratory Tract Diseases (44) · Hypersensitivity (41) · Lung Diseases (33) · Bronchial Diseases (32) · Lung Diseases, Obstructive (31) · Nose Diseases (14) · Otorhinolaryngologic Diseases (14) · Rhinitis (13) · Rhinitis, Allergic (5) · Pathologic Processes (4) · Pathological Conditions, Signs and Symptoms (4) · Chronic Disease (2)
montelukast (4) · Budesonide (2) · Formoterol Fumarate (2) · benralizumab (2) · Albuterol (1) · Atropine (1) · Beclomethasone (1) · Bosentan (1) · Chlorpheniramine (1) · Cholecalciferol (1) · EA 575 extract (1) · Excipients (1) · Glycerol (1) · Magnesium Sulfate (1) · Minocycline (1)
Shanghai University of Traditional Chinese Medicine (5) · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (2) · Keymed Biosciences Co.Ltd (2) · Apotex Inc. (1) · Canadian Institute of Natural and Integrative Medicine (1) · Changi General Hospital (1) · China Medical University Hospital (1) · Evolutec Group (1) · Genrix (Shanghai) Biopharmaceutical Co., Ltd. (1) · Glenmark Pharmaceuticals Europe Ltd. (R&D) (1) · Global United Pharmaceutical Corporation (1) · Grupo Medifarma, S. A. de C. V. (1) · Guy Steuer (1) · Hospital General de Mexico (1) · Hubei Provincial Collaborative Innovation Center of Preventive Treatment by Acupuncture and Moxibust (1)
China (14) · United States (8) · United Kingdom (4) · Canada (3) · Mexico (2) · Singapore (2) · Finland (1) · Germany (1) · India (1) · Israel (1) · Italy (1) · Japan (1) · Poland (1) · Taiwan (1)
Luo Zhang (2) · Zhenhui Lu, Doctor (2) · Agnieszka Brzozowska, MD, PhD (1) · Alberto Papi, MD (1) · Andrew Wilson, MD, MRCP (UK) (1) · Anthony Yii, MB BChir (1) · Badri Rickhi, MB,BS,FRCPC (1) · Christopher Corrigan, MD, PhD (1) · Devi K Jhaveri, D.O. (1) · Eric Arrata, ND (1) · Erkki Savilahti, Professor (1) · Fangming Chen, MB (1) · Gail Gauvreau, PhD (1) · Guangjun Tang, MD (1)
PMID 12668793, PMID 14674933, PMID 15313870, PMID 15461603, PMID 15516669, PMID 15750716, PMID 15898976, PMID 16164444, PMID 16930249, PMID 18331513, PMID 18595980, PMID 19925886, PMID 19968632, PMID 20545698, PMID 20816182, PMID 21122901, PMID 21771118, PMID 21783242, PMID 22093109, PMID 22224763, PMID 22627366, PMID 23348417, PMID 23791985, PMID 24631153, PMID 24679069, PMID 25171868, PMID 25445859, PMID 25644617, PMID 26141263, PMID 26874355, PMID 26922931, PMID 26932169, PMID 26949057, PMID 27609406, PMID 27609408, PMID 27824606, PMID 28602936, PMID 28785597, PMID 28917723, PMID 29214012, PMID 29771013, PMID 29774680, PMID 29973284, PMID 30142344, PMID 30233198, PMID 30263032, PMID 30326954, PMID 30472801, PMID 31310686, PMID 31784348
2009 (1), 2018 (1)